Lataa...
Lithium: a key to the genetics of bipolar disorder
Since the 1950s, lithium salts have been the main line of treatment for bipolar disorder (BD), both as a prophylactic and as an episodic treatment agent. Like many psychiatric conditions, BD is genetically and phenotypically heterogeneous, but evidence suggests that individuals who respond well to l...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768965/ https://ncbi.nlm.nih.gov/pubmed/19691823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm79 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|